Endoscopic Stricture Management Device Market Growth, Size, Trends Analysis - By Product, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Endoscopic Stricture Management Device Market Introduction and Overview

According to SPER market research, 'Global Endoscopic Stricture Management Device Market Size- By Product, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Endoscopic Stricture Management Device Market is predicted to reach 1681.1 million by 2034 with a CAGR of 6.05%.

Medical equipment called endoscopic stricture management devices is used to identify, treat, and control gastrointestinal strictures. Strictures are abnormal narrowing or constrictions that can occur in any portion of the digestive system, including the oesophagus, stomach, small intestine, or colon. Several causes may lead to strictures, including inflammation, scarring, tumours, and past surgical operations. Endoscopic techniques are used to treat strictures, providing minimally invasive methods without the complications associated with open surgery.

Restraints: The industry confronts constraints such as the high cost of endoscopic treatments and instruments. In some regions, reimbursement difficulties impede market penetration significantly. Additionally, the difficulties in managing severe strictures and a lack of proficiency in performing sophisticated endoscopic procedures hinder market expansion to a certain degree.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Product, By Application, By End User

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical Inc, Becton, Dickinson and Company, Merit Medical Systems, Medi-Globe GmbH, PanMed Us, HOBBS MEDICAL, INC, Micro-Tech (Nanjing) Co., Ltd, Steris plc (Diagmed Healthcare), Taewoong Medical Co., Ltd.

Global Endoscopic Stricture Management Device Market Segmentation:

By Product: Based on the Product, Global Endoscopic Stricture Management Device Market is segmented as; Stents, Balloon Dilators, Balloon Inflation Devices, Bougie Dilators.

By Application: Based on the Application, Global Endoscopic Stricture Management Device Market is segmented as; Esophageal, Colonic, Pyloric, Biliary.

By End User: Based on the End User, Global Endoscopic Stricture Management Device Market is segmented as; Hospitals, Ambulatory Surgery Centers.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: MEDE2526

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Endoscopic Stricture Management Device Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Endoscopic Stricture Management Device Market

7. Global Endoscopic Stricture Management Device Market, By Product (USD Million) 2021-2034

7.1. Stents
- 7.1.1. Metal stents
- 7.1.2. Plastic stents
- 7.1.3. Biodegradable stents
7.2. Balloon dilators
- 7.2.1. Balloon dilator catheters
- 7.2.2. Balloon inflation devices
7.3. Bougie dilators
7.4. Other products

8. Global Endoscopic Stricture Management Device Market, By Application (USD Million) 2021-2034

8.1. Esophageal
8.2. Colonic
8.3. Pyloric
8.4. Biliary
8.5. Other applications

9. Global Endoscopic Stricture Management Device Market, By End User (USD Million) 2021-2034

9.1. Hospitals
9.2. Ambulatory surgery centers
9.3. Other end users

10. Global Endoscopic Stricture Management Device Market, (USD Million) 2021-2034

10.1. Global Endoscopic Stricture Management Device Market Size and Market Share

11. Global Endoscopic Stricture Management Device Market, By Region, (USD Million) 2021-2034

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. Boston Scientific Corporation
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Olympus Corporation
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. CONMED Corporation
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Cook Medical Inc
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Becton, Dickinson and Company
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Merit Medical Systems
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Medi-Globe GmbH
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. PanMed Us
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. HOBBS MEDICAL, INC
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. Micro-Tech (Nanjing) Co., Ltd
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Steris plc (Diagmed Healthcare)
- 12.11.1. Company details
- 12.11.2. Financial outlook
- 12.11.3. Product summary
- 12.11.4. Recent developments
12.12. Taewoong Medical Co., Ltd
- 12.12.1. Company details
- 12.12.2. Financial outlook
- 12.12.3. Product summary
- 12.12.4. Recent developments
12.13. Others